Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia.
Cui L, Liu Y, Pang Y, Qian T, Quan L, Cheng Z, Dai Y, Ye X, Pang Y, Shi J, Ke X, Wu D, Fu L.
Cui L, et al. Among authors: ye x.
Cancer Gene Ther. 2020 Feb;27(1-2):1-14. doi: 10.1038/s41417-019-0119-5. Epub 2019 Jul 11.
Cancer Gene Ther. 2020.
PMID: 31292516
Review.